P
Power Law company profile
PTC Therapeutics
Biotech & Life Sciences · South Plainfield, United States · Founded 1998 · IPO 2013 Unicorn
Valuation
$6.11B
Market cap · Apr/2026
Revenue
$823M
Latest reported FY
Global footprint
Where PTC Therapeutics has talent and traffic
AI talent share
0.3%
of workforce is AI talent
(3 of 1,152 staff)
(3 of 1,152 staff)
Core AI20.17%
Other AI10.09%
Non-AI workforce1,14999.74%
Web traffic by country
41K
monthly visits
across markets
across markets
🇺🇸 United States58.8%
🇮🇳 India6.6%
🏳️ Korea6.6%
🏳️ Republic of6.3%
🇬🇧 United Kingdom5.1%
Patent intelligence
$184M patent portfolio · 129 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$184M
3.0% of market cap · comparable to top peer Amicus Therapeutics ($164M)
129 active patent families
Where PTC Therapeutics innovates
PharmacologyMedicinal chemistryMolecular biologySepiapterinPterin
Below peer median on Strategic
Quality vs same-sector peers
PTC Therapeutics on the five Patsnap quality dimensions
PTC Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where PTC Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across PTC Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee PTC Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.